Newsletter
Every new paper in this field, in your inbox.
A recent expert consensus from Chinese authorities presents a comprehensive framework for managing hepatocellular carcinoma (HCC) patients, addressing the complexities posed by chronic liver disease. The 2023 guidelines include 18 recommendations focusing on diagnosis, treatment, and follow-up. These pathways encompass both surgical and nonsurgical strategies,…
Online preoperative and postoperative risk scores have been developed and validated for predicting early recurrence in patients with hepatocellular carcinoma (HCC) undergoing conversion liver resection after treatment with tyrosine kinase inhibitors and immune checkpoint inhibitors. The preoperative model identified key factors, achieving a c-index of…
Mucinous pancreatic cystic lesions (PCLs) significantly increase cancer risk but can be difficult to identify. A study indicates that endoscopic ultrasound-guided intracystic glucose measurement effectively distinguishes mucinous from non-mucinous PCLs, boosting sensitivity to 88-95% and specificity to 76-91%, surpassing traditional carcinoembryonic antigen (CEA) tests. By…
A systematic review revealed that endoscopic retrograde cholangiopancreatography (ERCP) achieves an impressive 89% success rate in treating traumatic pancreatic injuries (TPI). The procedure notably enhanced pancreatic duct integrity and led to lower complication rates (4-17%), primarily pancreatitis and bleeding. Mortality remained low at 3-5%, and…
Carboxypeptidase Z (CPZ) emerges as a promising diagnostic biomarker for hepatocellular carcinoma (HCC), showing a remarkable 90.8% positive expression rate in a study of tumor tissues. In combination with other markers, CPZ achieved sensitivities up to 79.2% and specificities near 100%. Notably, it outperformed other…
A study examining 715 patients undergoing liver resection for hepatocellular carcinoma and intrahepatic cholangiocarcinoma found that the lymphocyte-C-reactive protein ratio (LCR) could accurately predict postoperative complications, recurrence-free survival, and overall survival. An optimal LCR cutoff of 6100 was established, with lower levels associated with increased…
Achievements in textbook outcomes (TO) for pancreatic surgery rose from 47% to 80.7% post-establishment of a specialized unit, indicating better surgical quality. Patients who met TO criteria showed notable overall survival rates at 1, 2, and 3 years: 86.9%, 55.7%, and 41%, compared to 62.7%,…
A novel prognostic nomogram was developed to assess cancer-specific survival (CSS) in patients with distant-metastatic hepatocellular carcinoma (dm-hcc). Using data from 651 patients, the model identified key predictors: alpha-fetoprotein levels, tumor grade, T stage, and treatment types. The nomogram achieved a c-index of 0.721 and…
AI algorithms were utilized to analyze 481 laparoscopic cholecystectomy videos, revealing that operative time elongated with case complexity. The study found that consultants had a longer duration of anatomy visualization compared to trainees, particularly in complex cases, with the cystic duct often identified before the…
A novel machine learning model has been developed by researchers to predict survival in metastatic pancreatic neuroendocrine tumors (PNETs), a condition traditionally associated with poor prognosis. Utilizing data from 1430 patients, the model employed the extreme gradient boosting (XGBoost) algorithm and integrated ten prognostic factors.…
